The Possibility of Differentiation between Nonalcoholic Steatohepatitis and Fatty Liver in Rabbits on Gd-EOB-DTPA-enhanced Open-type MRI Scans

Academic Radiology

Volumn 18, Issue 4, 2011, Pages 525-529

  Sonoda, Akinaga ^a   Nitta, Norihisa ^a   Ohta, Shinich ^a   Nitta Seko, Ayumi ^a   Tsuchiya, Keiko ^a   Nagatani, Yukihiro ^a   Mukaisho, Kenichi ^a   Takahashi, Masashi ^a   Murata, Kiyoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Animal research; Digestive system; Gd EOB DTPA; MRI

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM ETHOXYBENZYL DIETHYLENETRIAMINE PENTAACETIC ACID; GADOLINIUM PENTETATE DERIVATIVE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FEMALE; HISTOLOGY; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RABBIT;

ANIMALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79952195429     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.11.018     Document Type: Article

References (14)

1. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-438.
2. Portincasa P., Grattagliano I., Palmieri V.O., et al. The emerging problem of nonalcoholic steatohepatitis (NASH). Rom J Gastroenterol 2005, 14:43-51.
3. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12:1106-1110.
4. Lall C.G., Aisen A.M., Bansal N., et al. Nonalcoholic fatty liver disease. AJR Am J Roentgenol 2008, 190:993-1002.
5. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
6. Evans C.D., Oien K.A., MacSween R.N., et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?. J Clin Pathol 2002, 55:689-692.
7. Reid A.E. Nonalcoholic steatohepatitis. Gastroenterology 2001, 121:710-723.
8. Tsuda N., Okada M., Murakami T. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol 2007, 42:242-247.
9. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
10. Brunt E.M. Nonalcoholic steatohepatitis. Semin Liver Dis 2004, 24:3-20.
11. Schwenzer N.F., Springer F., Schraml C., et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009, 51:433-445.
12. d'Assignies G., Ruel M., Khiat A., et al. Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 2009, 19:2033-2040.
13. DeLeo M.J., Gounis M.J., Hong B., et al. Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study. Radiology 2009, 252:696-703.
14. Keilholz S.D., Bozlar U., Fujiwara N., et al. MR diagnosis of a pulmonary embolism: comparison of P792 and Gd-DOTA for first-pass perfusion MRI and contrast-enhanced 3D MRA in a rabbit model. Korean J Radiol 2009, 10:447-454.